Smoking remains the leading cause of preventable illness and early death in Wales, with wide-ranging impacts that extend beyond individual health to affect services, communities and the wider system.

While prevalence has declined over recent decades, tobacco use continues to shape demand across respiratory care pathways, from early diagnosis through to long-term condition management and acute services.

This article explores the current picture in Wales and what it means for those working across respiratory care.

A continued driver of respiratory disease

Smoking is a primary risk factor for many of the conditions seen across respiratory services, including COPD, lung cancer and chronic respiratory illness.

It contributes to both the development and progression of disease, often resulting in more complex clinical presentations and increased need for ongoing management.

Research suggests that each cigarette can reduce life expectancy by around 20 minutes, highlighting the cumulative impact of long-term smoking on patient outcomes.

For services, this translates into sustained demand across primary, community and secondary care settings.

Impact on healthcare demand in Wales

Smoking-related illness continues to place significant pressure on NHS Wales.

Each year, smoking is associated with:

The cost of treating smoking-related disease is estimated at approximately £302 million annually in Wales, with wider economic impacts reaching around £790 million.

For respiratory teams, this is reflected in high levels of service use, particularly in relation to exacerbations, admissions and long-term management of chronic conditions.

Reducing smoking prevalence remains one of the most effective ways to reduce this demand.

Financial pressures and patient context

The financial cost of smoking has increased significantly, with a pack of cigarettes now typically costing £15 to £17.

For someone smoking around 20 cigarettes a day, this equates to over £6,000 per year.

For many patients, particularly those managing long-term conditions or living in more deprived areas, this level of spending can contribute to wider financial stress.

This context is important in clinical conversations. Smoking is often closely linked with stress, mental health, and social circumstances, which can influence both behaviour and engagement with support.

Smoking and health inequalities

Smoking remains a key contributor to health inequalities in Wales.

Prevalence varies significantly across population groups, with higher rates seen in more deprived communities. For example, smoking rates are notably higher among people living in social housing compared with homeowners.

This contributes to unequal patterns of disease, earlier onset of chronic conditions, and reduced life expectancy in some communities.

Addressing smoking is therefore not only a clinical priority, but a central part of reducing health inequalities across Wales.

Early intervention and prevention

Current policy in Wales places increasing emphasis on prevention and early intervention, recognising the long-term benefits for both patients and services.

In the 2024–25 National Survey for Wales, 10% of people aged 16+ reported smoking.

There is a clear opportunity across respiratory pathways to integrate brief advice, referral and support into routine care, particularly at key touchpoints such as diagnosis, hospital admission and follow-up.

Supporting people to quit

Evidence consistently shows that people are more likely to quit successfully with the right support.

In Wales, Help Me Quit provides free, evidence-based support, including behavioural interventions and access to pharmacotherapy.

Patients who access combined support are significantly more likely to stop smoking compared with those attempting to quit without assistance.

For respiratory professionals, signposting to these services remains a key part of improving outcomes and supporting long-term condition management.

A system-wide priority

Wales has set an ambition to become smoke-free by 2030, with prevalence reduced to 5% or below.

Achieving this will require sustained action across prevention, treatment and policy, alongside continued collaboration between services and sectors.

For the respiratory community, this presents an important opportunity.

Reducing smoking prevalence has a direct impact on demand, outcomes and patient experience. It also supports a shift towards more sustainable services, with greater focus on prevention and early intervention.

The role of the respiratory community

For those working across respiratory care in Wales, smoking remains central to both clinical practice and wider system pressures.

Supporting patients to stop smoking is one of the most effective interventions available, with benefits seen across disease progression, quality of life and service demand.

Through shared learning, collaboration and consistent approaches, there is an opportunity to strengthen how smoking cessation is embedded across pathways.

Adele Pember
Author: Adele Pember

Hi everyone! 👋 I'm Adele, and I've been working behind the scenes designing and building the new Welsh Thoracic Society website and Member Hub! It's been lovely bringing everything together and I really hope you enjoy exploring the new site. If you come across anything that doesn't look quite right, have any ideas or suggestions, or just need a little help with something, please pop me a message. I'm always happy to help!

One Response

Leave a Reply

Your email address will not be published. Required fields are marked *